During the past decade, Sarah Cannon Research Institute - Methodist Healthcare conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sarah Cannon Research Institute - Methodist Healthcare" #1 collaborator was "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sarah Cannon Research Institute - Methodist Healthcare" are "Burkitt Lymphoma" (2 trials), "Chronic Lymphocytic Leukemia (CLL)" (2 trials), "Follicular Lymphoma (FL)" (2 trials), "Lymphoplasmacytic Lymphoma" (2 trials) and "Marginal Zone Lymphoma (MZL)" (2 trials). Many other conditions were trialed in "Sarah Cannon Research Institute - Methodist Healthcare" in a lesser frequency.

Most popular intervention types in "Sarah Cannon Research Institute - Methodist Healthcare" are "Biological" (2 trials), "Combination Product" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CLBR001 and SWI019" (2 trials), "P-BCMA-ALLO1 CAR-T cells" (1 trials), "Rimiducid" (1 trials) and "UCARTCS1A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sarah Cannon Research Institute - Methodist Healthcare" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sarah Cannon Research Institute - Methodist Healthcare". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Sarah Cannon Research Institute - Methodist Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sarah Cannon Research Institute - Methodist Healthcare, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".